AVTX (STOCKS)
Avalo Therapeutics, Inc. Common Stock
$14.600000
-0.160000 (-1.08%)
Prev close: $14.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Garry Arthur Neil
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $766.93M
- Employees
- 23
- P/E (TTM)
- -2.51
- P/B (TTM)
- 5.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.98 | $-1.05 | +0.0661 | +6.32% |
|
Dec 2025 (Q4)
|
$-1.13 | $-1.49 | +0.3633 | +24.33% |
|
Sep 2025 (Q3)
|
$-2.19 | $-1.69 | -0.4981 | -29.44% |
|
Jun 2025 (Q2)
|
$-1.92 | $-1.43 | -0.4869 | -33.98% |
Financial Statements
| Revenues | $59.00K |
| Costs And Expenses | $79.22M |
| Nonoperating Income/Loss | -$5.41M |
| Operating Income/Loss | -$79.16M |
| Income/Loss From Continuing Operations After Tax | -$84.74M |
| Income/Loss From Continuing Operations Before Tax | -$84.57M |
| Income Tax Expense/Benefit | $169.00K |
| Income Tax Expense/Benefit, Deferred | $169.00K |
| Net Income/Loss | -$84.74M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$84.74M |
| Net Income/Loss Available To Common Stockholders, Basic | -$84.74M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.46 |
| Diluted Earnings Per Share | -$5.46 |
| Basic Average Shares | 46,546,156 |
| Diluted Average Shares | 46,546,156 |
| Assets | $99.89M |
| Current Assets | $88.83M |
| Cash | $82.00M |
| Other Current Assets | $6.83M |
| Noncurrent Assets | $11.06M |
| Liabilities | $31.57M |
| Current Liabilities | $11.60M |
| Accounts Payable | $356.00K |
| Wages | $1.75M |
| Other Current Liabilities | $9.49M |
| Noncurrent Liabilities | $19.97M |
| Equity | $68.32M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $68.32M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $99.89M |
| Net Cash Flow From Operating Activities | -$59.69M |
| Net Cash Flow From Operating Activities, Continuing | -$59.69M |
| Net Cash Flow From Investing Activities | -$56.22M |
| Net Cash Flow From Financing Activities | $15.99M |
| Net Cash Flow | -$99.92M |
| Net Cash Flow, Continuing | -$99.92M |
| Comprehensive Income/Loss | -$84.75M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$84.75M |
| Other Comprehensive Income/Loss | -$84.75M |